厦门港务发展股份有限公司 简式权益变动报告书 上市公司：厦门港务发展股份有限公司 上市地点：深圳证券交易所 股票简称：厦门港务 股票代码：000905 信息披露义务人：厦门国际港务有限公司 住所：厦门市海沧区港南路 439 号 通讯地址：厦门市湖里区东港北路 31 号港务大厦 22 楼 权益变动性质：持股数量增加（因发行股份购买资产事宜） 签署日期：二〇二五年八月五日 厦门港务发展股份有限公司 简式权益变动报告书 信息披露义务人声明 一、本报告书系信息披露义务人依据《公司法》 《证券法》 《收购办法》 《公开发行证 券的公司信息披露内容与格式准则第 15 号——权益变动报告书》及其他相关法律、法 规及规范性文件编写。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反信息 披露义务人章程或内部规则中的任何条款，或与之相冲突。 三、依据《证券法》 《收购办法》 《公开发行证券的公司信息披露内容与格式准则第 拥有权益的股份变动情况。截至本报告书签署日，除本报告书披露的信息外，信息披露 义务人没有通过任何其他方式增加或减少其在厦门港务中拥有权益的股份。 四、本次权益变动是根据本报告书所载明的资料进 ...

上海罗曼科技股份有限公司 简式权益变动报告书 上市公司名称：上海罗曼科技股份有限公司 股票简称：罗曼股份 股票代码：605289 上市地点：上海证券交易所 信息披露义务人名称：上海八荒武桐企业管理合伙企业（有限合伙） 注册地址：上海市杨浦区国定路 335 号 2 号楼 2101 室（集中登记地） 股份变动性质：股份增加（协议转让） 签署日期：2025 年 8 月 5 日 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》（以下简称为《证券法》）、 《上市公司收购管理办法》（以下简称"《收购管理办法》"）、《公开发行证券的公 司信息披露内容与格式准则第 15 号——权益变动报告书》 （以下简称"《准则 15 号》"） 及其他相关的法律、法规和规范性文件编写本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反信息 披露义务人公司章程或内部规则中的任何条款，或与之相冲突。 三、依据《证券法》《收购管理办法》《准则 15 号》的规定，本报告书已全面披 露信息披露义务人在上海罗曼科技股份有限公司中拥有权益的股份变动情况。 四、截止本报告书签署之日，除本报告书披露的持股信息外， ...

上市公司名称：深圳震有科技股份有限公司 股票上市地点：上海证券交易所 股票简称：震有科技 证券代码：688418 证券简称：震有科技 深圳震有科技股份有限公司 简式权益变动报告书 公司住所：深圳市宝安区新安街道大宝路一巷友谊大厦 501 室 通讯地址：深圳市福田区诺德金融中心 37D2 股权变动性质：股份增加（协议转让） 签署日期：2025 年 8 月 1 日 声明 一、信息披露义务人依据《中华人民共和国证券法》《上市公司收购管理 办法》《公开发行证券的公司信息披露内容与格式准则第 15 号——权益变动报 告书》等相关法律、法规和规范性文件编制本报告书。 股票代码：688418 信息披露义务人：深圳世纪致远私募证券基金管理有限公司（代表致远资本价 值 2 号私募证券投资基金） 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不 违反信息披露义务人章程或内部规则中的任何条款，或与之冲突。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》等规定， 本报告书已全面披露信息披露义务人在深圳震有科技股份有限公司中拥有权益 的股份变动情况。 截至本报告书签署之日，除本报告书披露的持股信息外，信息披露 ...

南京三超新材料股份有限公司 简式权益变动报告书 上市公司：南京三超新材料股份有限公司 股票上市地：深圳证券交易所 股票简称：三超新材 股票代码：300554.SZ 信息披露义务人名称：邹余耀 通讯地址：南京市江宁区淳化街道泽诚路 77 号 股份变动性质：股份减少（协议转让、表决权放弃、被动稀释） 签署日期：2025 年 8 月 1 日 信息披露义务人声明 一、 本报告书系信息披露义务人依据《中华人民共和国公司法》（以下简称"《公 司法》"）《中华人民共和国证券法》（以下简称"《证券法》"）《上市公司收购管理办 法》（以下简称"《收购管理办法》"）《公开发行证券的公司信息披露内容与格式准则 第 15 号——权益变动报告书》（以下简称"《准则 15 号》"）等相关法律、法规和规范 性文件编制。 二、 信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反信 息披露义务人章程或内部规则中的任何条款，或与之相冲突。 三、 依据《公司法》《证券法》《收购管理办法》《准则 15 号》，本报告书已全 面披露了信息披露义务人所拥有的南京三超新材料股份有限公司权益的股份变动情况。 截至本报告书签署日，除本报告书披露的 ...

大恒新纪元科技股份有限公司 详式权益变动报告书 上市公司名称：大恒新纪元科技股份有限公司 上市地点：上海证券交易所 股票简称：大恒科技 股票代码：600288 信息披露义务人：李蓉蓉 住所：浙江省宁波市江北区庄桥街道 通讯地址：浙江省宁波市江北区庄桥街道 股份变动性质：股份增加（司法拍卖，执行法院裁定） 签署日期：2025年8月4日 信息披露义务人声明 一、本报告书依据《中华人民共和国证券法》、《上市公司收购管理办法》、 《公开发行证券的公司信息披露内容与格式准则第15号—权益变动报告书》、 《公开发行证券的公司信息披露内容与格式准则第16号—上市公司收购报告书》 及其他相关法律、法规及部门规章的有关规定编写。 二、依据《证券法》、《收购办法》、《准则第15号》、《准则第16号》的 规定，本报告书已全面披露了信息披露义务人在大恒新纪元科技股份有限公司拥 有权益的股份。 截至本报告书签署日，除本报告书披露的持股信息外，信息披露义务人没有 通过任何其他方式在大恒新纪元科技股份有限公司中拥有权益。 三、本信息披露义务人签署本报告书已获得必要的授权和批准。 四、本次权益变动是根据本报告书所载明的资料进行的。除信息披露 ...

Core Viewpoint - The announcement details the changes in equity ownership of Diou Home Group Co., Ltd. due to the conversion of convertible bonds, which does not alter the actual control of the company [2][3][6]. Group 1: Equity Changes - Zhang Zhi-Huan, an associated party of the actual controller Zhu Jiang, converted 1,049,870 "Diou Convertible Bonds" into shares, increasing the combined ownership of Zhu Jiang and his associates to 29.60% from 26.61% [2][3]. - The total shares increased by 5,427,645 due to the conversion of bonds, with the conversion completed on August 1, 2025 [3][6]. - The equity change does not lead to a change in actual control or affect the company's governance structure [3][6]. Group 2: Convertible Bonds Information - As of July 31, 2025, a total of 90,559,166 shares have been converted from "Diou Convertible Bonds," representing 23.41% of the total shares issued before the conversion [11][18]. - There are still 10,379,207 "Diou Convertible Bonds" unconverted, which is 69.19% of the total issued bonds [11][18]. - The initial conversion price was set at 13.53 CNY per share, which has undergone adjustments due to various corporate actions [13][14][15][17]. Group 3: Share Buyback Progress - The company approved a share buyback plan on July 10, 2024, with a range of 8,500,000 to 16,700,000 shares to be repurchased at a maximum price of 5.00 CNY per share [22][24]. - The buyback price limit was later adjusted to 8.40 CNY per share, and the buyback period was extended by six months [23][24]. - As of July 31, 2025, the company has repurchased 3,034,800 shares, accounting for 0.6385% of the total share capital, with a total transaction amount of 13,825,395 CNY [21][24].

Core Viewpoint - The report outlines the equity change of Shanghai Xintonglian Packaging Co., Ltd., indicating a reduction in shareholding by Wuhu Yuance Bifang Investment Center (Limited Partnership) due to funding needs and the impact of the company's stock incentive plan [1][4]. Group 1: Equity Change Details - The information disclosing party has reduced its shareholding from 10.45% to 10.00% by selling 903,700 shares, which accounts for 0.45% of the total shares [5]. - The reduction in shareholding is attributed to the party's funding requirements and the effects of the company's stock incentive plan [4]. - The party plans to further reduce its holdings by up to 6,000,000 shares, representing no more than 3% of the total shares, within three months following the announcement of the reduction plan [4]. Group 2: Compliance and Legal Statements - The report confirms that the information disclosing party has complied with relevant laws and regulations, ensuring that the report does not contain any false statements or significant omissions [2][8]. - The party has not engaged in any other transactions involving the company's shares in the six months prior to the report's signing [7]. - The report has been made available for investor review at the company's office and the Shanghai Stock Exchange [9].

Core Viewpoint - Chengdu Yingchuang Power Venture Capital Co., Ltd. has reduced its stake in Haichuang Pharmaceutical Co., Ltd. to 5% as part of its funding needs, resulting in a decrease of 5,617,669 shares from its previous holding of 10,568,449 shares, which represented 10.67% of the total shares before the reduction [1][4][10]. Group 1: Company Information - Haichuang Pharmaceutical Co., Ltd. is listed on the Shanghai Stock Exchange under the stock code 688302 [1]. - The registered address of Haichuang Pharmaceutical is located in the Chengdu High-tech Zone, Sichuan, China [1]. Group 2: Shareholding Changes - The shareholding change was executed without any additional conditions and was based on the information disclosed in the report [2]. - The reduction in shares occurred between July 12, 2023, and July 31, 2025, through centralized bidding and block trading [6]. - The average reduction price ranged from 24.82 to 63.17 yuan per share [6]. Group 3: Future Plans - Chengdu Yingchuang Power Venture Capital plans to continue evaluating its shareholding in Haichuang Pharmaceutical over the next 12 months, depending on market conditions and the company's business development [6][10]. - The company has announced a plan to reduce up to 1,980,310 shares, which has not yet been completed as of the report date [6]. Group 4: Impact on Company - The reduction in shareholding will not lead to a change in control of Haichuang Pharmaceutical and will not significantly impact its governance structure or ongoing operations [7].

Core Viewpoint - The report outlines the equity change of Huashu Holdings Co., Ltd., indicating an increase in shareholding by Tianjin Xinshi Management Consulting Partnership (Limited Partnership), which now indirectly holds 11.47% of the company's shares through the acquisition of 100% equity in Xintong Wanhua [1][5]. Group 1: Equity Change Details - Tianjin Xinshi acquired 100% equity of Xintong Wanhua, which directly holds shares in Huashu Holdings, resulting in Tianjin Xinshi indirectly holding 12,309,000 shares, representing 11.47% of the total share capital [5][6]. - The equity change was executed through a debt acquisition, allowing Tianjin Xinshi to assume Xintong Wanhua's assets and liabilities, thereby improving the shareholding structure of Huashu Holdings [5][7]. Group 2: Information Disclosure Obligations - The report confirms that Tianjin Xinshi has no other direct holdings in any domestic or foreign listed companies exceeding 5% as of the report's signing date [5]. - The report asserts that there are no false records, misleading statements, or significant omissions, and Tianjin Xinshi is responsible for the accuracy and completeness of the information provided [2][9]. Group 3: Future Plans and Restrictions - Tianjin Xinshi has no plans to increase or decrease its shareholding in Huashu Holdings within the next 12 months, but will disclose any changes as required by law [5][11]. - The shares involved in this equity change are not subject to judicial freezes or other rights restrictions, although 9,848,000 shares are pledged to Tianjin Xinshi as part of the debt acquisition [8].

Core Viewpoint - The actual controller and its concerted actors of Shanghai Yaoji Technology Co., Ltd. have reduced their shareholding from 53.86% to 49.61%, triggering a change that touches the 5% integer multiple threshold [1][2][4]. Group 1: Shareholding Changes - The shareholding of the actual controller and its concerted actors decreased from 53.86% to 49.61%, indicating a significant reduction in control [1][2]. - The reduction in shareholding is attributed to both share sales and passive dilution due to the implementation of an equity incentive plan, resulting in a total of 17,690,668 new shares being added [3][4]. Group 2: Share Transfer Details - Internal transfers among concerted actors included significant transactions, such as 5,000,000 shares transferred to the Tai Run Fund and 6,929,419 shares to the Abama Fund [2][3]. - The total shares transferred during the reporting period amounted to 8,200,000 shares, affecting the overall shareholding structure [3]. Group 3: Future Plans and Commitments - The actual controller and concerted actors plan to reduce their holdings by up to 12,524,155 shares, representing 3% of the total share capital, within three months following the announcement [4][5]. - The company has confirmed that all commitments regarding shareholding restrictions have been adhered to, with no violations reported [5].